​
Login / Signup
Congjun Wang
ORCID
Publication Activity (10 Years)
Years Active: 2024-2024
Publications (10 Years): 3
Top Topics
Squamous Cell Carcinoma
Early Stage
Rna Seq
Intensive Care Unit
Top Venues
Molecular biotechnology
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
Jie Zheng
,
Fengling Liu
,
Jinwei Tuo
,
Siyu Chen
,
Jinxia Su
,
Xiuyi Ou
,
Min Ding
,
Haoran Chen
,
Bo Shi
,
Yong Li
,
Xun Chen
,
Congjun Wang
,
Cheng Su
Multidimensional Transcriptomics Unveils RNF34 as a Prognostic Biomarker and Potential Indicator of Chemotherapy Sensitivity in Wilms' Tumour.
Molecular biotechnology
66 (5) (2024)
Jie Zheng
,
Fengling Liu
,
Jinwei Tuo
,
Siyu Chen
,
Jinxia Su
,
Xiuyi Ou
,
Min Ding
,
Haoran Chen
,
Bo Shi
,
Yong Li
,
Xun Chen
,
Congjun Wang
,
Cheng Su
Multidimensional Transcriptomics Unveils RNF34 as a Prognostic Biomarker and Potential Indicator of Chemotherapy Sensitivity in Wilms' Tumour.
Molecular biotechnology
(2024)
Jie Zheng
,
Fengling Liu
,
Jinwei Tuo
,
Siyu Chen
,
Jinxia Su
,
Xiuyi Ou
,
Min Ding
,
Haoran Chen
,
Bo Shi
,
Yong Li
,
Xun Chen
,
Congjun Wang
,
Cheng Su
Multidimensional Transcriptomics Unveils RNF34 as a Prognostic Biomarker and Potential Indicator of Chemotherapy Sensitivity in Wilms' Tumour.
Molecular biotechnology
66 (5) (2024)